{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T20:00:33Z","timestamp":1774468833329,"version":"3.50.1"},"reference-count":27,"publisher":"The Journal of Rheumatology","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Rheumatol"],"published-print":{"date-parts":[[2020,5,1]]},"abstract":"<jats:sec><jats:title>Objective.<\/jats:title><jats:p>To assess longterm effectiveness of tumor necrosis factor inhibitors (TNFi) in patients with psoriatic arthritis (PsA) registered in the Rheumatic Diseases Portuguese Register, exposed to at least 1 TNFi, prospectively followed between 2001 and 2017.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods.<\/jats:title><jats:p>Kaplan-Meier analysis was performed for first-, second-, and third-line TNFi. Responses included European League Against Rheumatism (EULAR) criteria, Disease Activity Index for Psoriatic Arthritis (DAPSA), minimal disease activity (MDA), and Ankylosing Spondylitis Disease Activity Score (ASDAS) at 3 and 6 months. Baseline predictors of discontinuation and response were studied using Cox and multivariable multinomial\/logistic regression models.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results.<\/jats:title><jats:p>The 750 patients with PsA showed drug retention of 4.1 \u00b1 3.4 years (followup 5.8 \u00b1 3.8 yrs) for first TNFi. Switching to a second (189 patients) or third (50 patients) TNFi further decreased survival by 1.1 years. Female sex, higher baseline 28-joint count Disease Activity Score, and infliximab were predictors of first TNFi discontinuation. After 6 months of the first TNFi, 48.7% of patients achieved a good EULAR criteria response and 20.9% were in DAPSA remission. There were 11.4% in MDA, and 56.4% had a good ASDAS. Responses to the second TNFi were significantly inferior compared to responses to the first TNFi. Female sex and higher baseline Health Assessment Questionnaire\u2013Disability Index were negatively associated with good EULAR response at 3 months, and obesity decreased the chance of response at 6 months.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion.<\/jats:title><jats:p>In this study, switching to a second or third TNFi was associated with significantly lower drug survival and response rates for patients with axial and peripheral PsA subtypes. More successful therapeutic approaches will require considering the effect of sex and obesity on TNFi effectiveness.<\/jats:p><\/jats:sec>","DOI":"10.3899\/jrheum.181272","type":"journal-article","created":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T16:15:22Z","timestamp":1564676122000},"page":"690-700","source":"Crossref","is-referenced-by-count":20,"title":["Real-world Longterm Effectiveness of Tumor Necrosis Factor Inhibitors in Psoriatic Arthritis Patients from the Rheumatic Diseases Portuguese Register"],"prefix":"10.3899","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7170-8802","authenticated-orcid":false,"given":"Elsa","family":"Vieira-Sousa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6762-7818","authenticated-orcid":false,"given":"M\u00f3nica","family":"Eus\u00e9bio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3177-0206","authenticated-orcid":false,"given":"Pedro","family":"\u00c1vila-Ribeiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6358-7388","authenticated-orcid":false,"given":"Nikita","family":"Khmelinskii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0600-876X","authenticated-orcid":false,"given":"Rita","family":"Cruz-Machado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2694-0952","authenticated-orcid":false,"given":"Teresa Martins","family":"Rocha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1849-5465","authenticated-orcid":false,"given":"Miguel","family":"Bernardes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0211-7440","authenticated-orcid":false,"given":"Daniela","family":"Santos-Faria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6808-6520","authenticated-orcid":false,"given":"Joana Leite","family":"Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1396-8988","authenticated-orcid":false,"given":"Helena","family":"Santos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3841-4834","authenticated-orcid":false,"given":"Cl\u00e1udia","family":"Miguel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8255-4274","authenticated-orcid":false,"given":"Pedro","family":"Carvalho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiago","family":"Costa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6128-2425","authenticated-orcid":false,"given":"Ana Catarina","family":"Duarte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0456-1281","authenticated-orcid":false,"given":"Tiago","family":"Meirinhos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patr\u00edcia","family":"Nero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1432-3671","authenticated-orcid":false,"given":"Jo\u00e3o Eurico","family":"Fonseca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7946-1365","authenticated-orcid":false,"given":"Maria Jos\u00e9","family":"Santos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2262","published-online":{"date-parts":[[2019,8,1]]},"reference":[{"key":"2020050109252815000_47.5.690.1","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1517\/14712598.2014.967211","article-title":"Tumour necrosis factor inhibitors in the treatment of psoriatic arthritis: a view on effectiveness, clinical practice and toxicity","volume":"14","author":"Lories","year":"2014","journal-title":"Expert Opin Biol Ther"},{"key":"2020050109252815000_47.5.690.2","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1093\/rheumatology\/kex387","article-title":"Prevalence and predictors of tumour necrosis factor inhibitor persistence in psoriatic arthritis","volume":"57","author":"Stober","year":"2018","journal-title":"Rheumatology"},{"key":"2020050109252815000_47.5.690.3","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2012-203018"},{"key":"2020050109252815000_47.5.690.4","doi-asserted-by":"publisher","DOI":"10.1016\/0049-0172(73)90035-8"},{"key":"2020050109252815000_47.5.690.5","first-page":"45","article-title":"Reuma.pt - the rheumatic diseases Portuguese register","volume":"36","author":"Canhao","year":"2011","journal-title":"Acta Reum Port"},{"key":"2020050109252815000_47.5.690.6","doi-asserted-by":"crossref","first-page":"83","DOI":"10.20344\/amp.7243","article-title":"Reuma.pt - case study","volume":"29","author":"Santos","year":"2016","journal-title":"Acta Med Port"},{"key":"2020050109252815000_47.5.690.7","first-page":"275","article-title":"Portuguese recommendations for the use of biological therapies in patients with psoriatic arthritis\u20142015 update","volume":"40","author":"Vieira-Sousa","year":"2015","journal-title":"Acta Reum Port"},{"key":"2020050109252815000_47.5.690.8","first-page":"176","article-title":"BioRePortAP, an electronic clinical record coupled with a database: an example of its use in a single centre","volume":"35","author":"Campanilho-Marques","year":"2010","journal-title":"Acta Reumatol Port"},{"key":"2020050109252815000_47.5.690.9","doi-asserted-by":"publisher","DOI":"10.1002\/art.21570"},{"key":"2020050109252815000_47.5.690.10","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a008670"},{"key":"2020050109252815000_47.5.690.11","doi-asserted-by":"publisher","DOI":"10.1186\/ar2670"},{"key":"2020050109252815000_47.5.690.12","doi-asserted-by":"publisher","DOI":"10.1002\/art.30117"},{"key":"2020050109252815000_47.5.690.13","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1007\/s10067-017-3593-x","article-title":"Impact of prior biologic use on persistence of treatment in patients with psoriatic arthritis enrolled in the US Corrona registry","volume":"36","author":"Harrold","year":"2017","journal-title":"Clin Rheumatol"},{"key":"2020050109252815000_47.5.690.14","doi-asserted-by":"publisher","DOI":"10.1186\/ar1881"},{"key":"2020050109252815000_47.5.690.15","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.semarthrit.2016.09.005","article-title":"Effectiveness and drug survival of TNF-inhibitors in the treatment of psoriatic arthritis: a prospective cohort study","volume":"46","author":"Aaltonen","year":"2017","journal-title":"Semin Arthritis Rheum"},{"key":"2020050109252815000_47.5.690.16","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2017-000596"},{"key":"2020050109252815000_47.5.690.17","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2007.082925"},{"key":"2020050109252815000_47.5.690.18","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2007.073544"},{"key":"2020050109252815000_47.5.690.19","doi-asserted-by":"publisher","DOI":"10.1002\/art.23333"},{"key":"2020050109252815000_47.5.690.20","doi-asserted-by":"publisher","DOI":"10.3109\/03009742.2014.962081"},{"key":"2020050109252815000_47.5.690.21","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.170477"},{"key":"2020050109252815000_47.5.690.22","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1093\/rheumatology\/key140","article-title":"Gender differences in biologic treatment outcomes-a study of 1750 patients with psoriatic arthritis using Danish Health Care Registers","volume":"57","author":"H\u00f8jgaard","year":"2018","journal-title":"Rheumatology"},{"key":"2020050109252815000_47.5.690.23","first-page":"55","article-title":"Predictors of response to TNF blockers in patients with polyarticular psoriatic arthritis","volume":"42","author":"Carvalho","year":"2017","journal-title":"Acta Reum Port"},{"key":"2020050109252815000_47.5.690.24","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kew326"},{"key":"2020050109252815000_47.5.690.25","doi-asserted-by":"crossref","first-page":"e0195123","DOI":"10.1371\/journal.pone.0195123","article-title":"Obesity and response to anti-tumor necrosis factor-\u03b1 agents in patients with select immune-mediated inflammatory diseases: A systematic review and meta-analysis","volume":"13","author":"Singh","year":"2018","journal-title":"PLoS One"},{"key":"2020050109252815000_47.5.690.26","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2015-000181"},{"key":"2020050109252815000_47.5.690.27","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2012-202347"}],"container-title":["The Journal of Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.3899\/jrheum.181272","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T16:27:16Z","timestamp":1588350436000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jrheum.org\/lookup\/doi\/10.3899\/jrheum.181272"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,1]]},"references-count":27,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2020,5,1]]},"published-print":{"date-parts":[[2020,5,1]]}},"alternative-id":["10.3899\/jrheum.181272"],"URL":"https:\/\/doi.org\/10.3899\/jrheum.181272","relation":{},"ISSN":["0315-162X","1499-2752"],"issn-type":[{"value":"0315-162X","type":"print"},{"value":"1499-2752","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,1]]}}}